Image copyright Reuters Image caption COVID is the first vaccine based on Enterovirus 71
Children in China will get a vaccine against a particularly severe form of childhood pneumonia, the country’s health ministry says.
Children under the age of three will receive the Chinese-developed COVID (Composite Vaccine for Enterovirus 73) vaccine.
Early tests have shown the vaccine can prevent 40% of cases of children who contract the disease, and over 90% of those who get severe diseases.
This form of childhood pneumonia kills almost half of children who contract it, according to the World Health Organization.
China currently provides vaccines against other more common forms of childhood pneumonia – such as pneumococcal disease and rotavirus – to all of its three million children.
In the case of other pneumococcal vaccines, those given at birth are pre-filled syringes, which can be expensive and require rigorous distribution, Dr Xiaoyan Yu from the China Centre for Disease Control and Prevention said.
Chinese-developed COVID is the first vaccine based on Enterovirus 71.
The vaccine – which has been approved by the Chinese Food and Drug Administration and the General Administration of Quality Supervision, Inspection and Quarantine – is manufactured by Jiangsu Yangzha Pharmaceutical and distributed by Hebei Sunndong Biotech.
Find out more about Flu season: